Angiotensin-Converting Enzyme Inhibitor (ACE inhibitor) Drugs

Angiotensin-converting enzyme inhibitor (ACE inhibitors) drugs include Benazepril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik).

 

To report any serious adverse events associated with the use of these drugs, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

• FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)

Labeling and Regulatory History from Drugs@FDA

• Regulatory History of Lotensin and Labeling Information
• Regulatory History of Capoten
• Regulatory History of Vasotec and Labeling Information
• Regulatory History of Monopril and Labeling Information
• Regulatory History of Zestril and Labeling Information
• Regulatory History of Prinivil and Labeling Information
• Regulatory History of Univasc
• Regulatory History of Aceon and Labeling Information
• Regulatory History of Accupril
• Regulatory History of Altace
• Regulatory History of Mavik